Assessing the Benefits of Drug Delivery by Nanocarriers: A Partico/Pharmacokinetic Framework
https://www.embs.org/tbme/wp-content/uploads/sites/19/2017/08/TBME010332016-sm.jpg
170
177
IEEE Transactions on Biomedical Engineering (TBME)
//www.embs.org/tbme/wp-content/uploads/sites/19/2022/06/ieee-tbme-logo2x.png
Nanocarriers, including solid nanoparticles, liposomes, dendrimers, and polymer micelles, are regarded as promising vehicles for targeted drug delivery, particularly for anticancer agents. Here, an in vivo kinetic framework is introduced…
read more